Contract HT941025P0022
Medpharm Inc. · Department Of Defense · June 30, 2025
Medpharm Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on June 30, 2025 for $523,000 (current value) of work in in-vitro diagnostic substance manufacturing. Performance is in Yigo, GU. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $1.46 million.
Contract details
- PIID
- HT941025P0022
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Yigo, GU
- First action
- June 30, 2025
Description
COAGULATION REAGENTS, CONSUMABLES, MAINTENANCE, AND THE LEASE OF EQUIPMENT STA COMPACT MAX3 2 UNITS FOR NAVAL HOSPITAL GUAM.
Modification timeline
-
June 30, 2025Mod P00001 · Supplemental Agreement For Work Within Scope$237.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT941025P0022?
Contract HT941025P0022 is a federal contract awarded to Medpharm Inc. by Department Of Defense on June 30, 2025 for $523,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HT941025P0022?
Medpharm Inc. won contract HT941025P0022 from Department Of Defense.
How much is contract HT941025P0022 worth?
Contract HT941025P0022 has obligated $0 to date but carries a potential ceiling of $1.46 million if fully funded and all options are exercised.